Improving Nurses' Knowledge of Metabolic Syndrome in Patients Receiving Antipsychotic Medication
Project Description: Adults with serious mental illness treated with antipsychotic medications are known to be at greater risk for developing or exacerbating risk factors for metabolic syndrome(MetS). The literature reflects that the increase in risk for MetS that patients' taking antipsychotic medications, particularly second generation antipsychotic medications (SGAs) experience, whether they take a single agent or multiple medications, appears to be in addition to, but independent of, mutable risk factors such as eating habits and activity level or any existing non-mutable risk factors that patients may be burdened with, such as gender or genetic factors. Registered nurses, including advanced practice registered nurses, have a duty to provide safe and effective care, which includes monitoring for medication side effects. Medication side effect monitoring for SGAs includes monitoring for MetS. Registered nurses have a responsibility to monitor for and act to prevent or mitigate development of MetS in patients treated with medications such as SGAs which are known to place patients at greater risk for developing MetS. Data reported by the Northeast Florida State (NEFSH) Hospital Quality Improvement department reveals nurse MetS monitoring is inconsistent with current practice standards. Evidence-based education and training will be provided to a convenience sample of consenting nursing staff at NEFSH in addition to workplace prompts to assist nurses with identifying and monitoring MetS. No patients or patient records will be involved in this QI project.
QPI: Merredith, Oakes, (firstname.lastname@example.org)
Collaborators: Tina, D'alessandro, (email@example.com)
Advisors: Tina, D'alessandro, (firstname.lastname@example.org)
UF Health Big Aims: Zero Harm None